Title / AuthorYear
Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease
F Labrie, SX Lin, J Simard, C Labrie, M El-Alfy, G Pelletier, A Bélanger
Journal of Molecular Endocrinology 25 (1), 1-16
2000
Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance
LA Lotta, P Gulati, FR Day, F Payne, H Ongen, M Van De Bunt, ...
Nature genetics 49 (1), 17
2017
Insulin action and resistance in obesity and type 2 diabetes
MP Czech
Nature medicine 23 (7), 804
2017
Regulation of hepatic glucose metabolism in health and disease
MC Petersen, DF Vatner, GI Shulman
Nature reviews endocrinology 13 (10), 572
2017
Mechanisms of NAFLD development and therapeutic strategies
SL Friedman, BA Neuschwander-Tetri, M Rinella, AJ Sanyal
Nature medicine 24 (7), 908
2018
Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity
G Jia, MA Hill, JR Sowers
Circulation research 122 (4), 624-638
2018
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
VT Samuel, GI Shulman
Cell metabolism 27 (1), 22-41
2018
Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?
A Lonardo, F Nascimbeni, A Mantovani, G Targher
Journal of hepatology 68 (2), 335-352
2018
Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis
A Kalinkovich, G Livshits
Ageing research reviews 35, 200-221
2017
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
AK Rines, K Sharabi, CDJ Tavares, P Puigserver
Nature Reviews Drug Discovery 15 (11), 786
2016
Cytosolic lipolysis and lipophagy: two sides of the same coin
R Zechner, F Madeo, D Kratky
Nature Reviews Molecular Cell Biology 18 (11), 671
2017
SREBP-regulated lipid metabolism: convergent physiology—divergent pathophysiology
H Shimano, R Sato
Nature Reviews Endocrinology 13 (12), 710
2017
Cardiovascular consequences of metabolic syndrome
JD Tune, AG Goodwill, DJ Sassoon, KJ Mather
Translational Research 183, 57-70
2017
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
Y Tang, M Wallace, J Sanchez-Gurmaches, WY Hsiao, H Li, PL Lee, ...
Nature communications 7, 11365
2016
Nonalcoholic fatty liver disease: Evolving paradigms
A Lonardo, F Nascimbeni, M Maurantonio, A Marrazzo, L Rinaldi, ...
World journal of gastroenterology 23 (36), 6571
2017
An integrated view of immunometabolism
YS Lee, J Wollam, JM Olefsky
Cell 172 (1-2), 22-40
2018
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV
A Lonardo, S Ballestri, G Guaraldi, F Nascimbeni, D Romagnoli, S Zona, ...
World journal of gastroenterology 22 (44), 9674
2016
Metabolic syndrome
SM Grundy
Diabetes Complications, Comorbidities and Related Disorders, 1-37
2018
Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance
KC Yang, HF Hung, CW Lu, HH Chang, LT Lee, KC Huang
Scientific reports 6, 27034
2016
Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome
MJ Saeedi Borujeni, E Esfandiary, G Taheripak, P Codoñer‐Franch, ...
Journal of cellular biochemistry 119 (2), 1257-1272
2018
1 - 20
Dates and citation counts are estimated and are determined automatically by a computer program.